Skip to main content
Clinical Trials/NCT03132558
NCT03132558
Unknown
Not Applicable

Contrast Induced Acute Kidney in Patients With Acute Stroke

Nanjing Medical University1 site in 1 country200 target enrollmentSeptember 2016

Overview

Phase
Not Applicable
Intervention
Radiopaque Media
Conditions
Stroke, Acute
Sponsor
Nanjing Medical University
Enrollment
200
Locations
1
Primary Endpoint
Creatinine
Last Updated
8 years ago

Overview

Brief Summary

Computed tomographic angiography (CTA) is recommended for identifying eligible patient with acute ischemic stroke (AIS) to receieve endovascular treatment. We are going to conduct this prospective corhot study to observe if sequential use contrast in CTA examination and in endovascular treatment will cause acute kidney injury.

Registry
clinicaltrials.gov
Start Date
September 2016
End Date
December 2017
Last Updated
8 years ago
Study Type
Observational
Sex
All

Investigators

Sponsor
Nanjing Medical University
Responsible Party
Principal Investigator
Principal Investigator

Hai-Bin Shi

Professor

Nanjing Medical University

Eligibility Criteria

Inclusion Criteria

  • All patients who are suspected with AIS.
  • Non-contrast head CT excludes intracranial hemorrhage.

Exclusion Criteria

  • Lacking of pre-CTA Creatinine
  • Lacking of post-angiography Creatinine with 24-48 hours

Arms & Interventions

CTA

Patients with AIS only receieved cerebral CTA exam.

Intervention: Radiopaque Media

CTA+DSA

Patients with AIS receieved cerebral CTA, followed by endovascular treatment with the guidence of digital substration angiography (DSA).

Intervention: Radiopaque Media

Outcomes

Primary Outcomes

Creatinine

Time Frame: within 24h to 48h

Contrast-induced acute kidney injury was defined as a relative increase of 25% or an absolute increase of 0.3 mg/dL (28.2mol/L) in the serum creatinine level at 48 hours following angiography

Study Sites (1)

Loading locations...

Similar Trials